主要文件

查看所有文档

08088

对氨基马尿酸

Name: 对氨基马尿酸
Brand: SIAL

puriss., ≥99.0% (T)

别名:

4-氨基马尿酸, N-(4-氨基苯甲酰基)甘氨酸

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

NH₂C₆H₄C(O)NHCH₂COOH

化学文摘社编号:

61-78-9

分子量:

194.19

EC Number:

200-518-9

UNSPSC Code:

12352200

MDL number:

MFCD00007890

Beilstein/REAXYS Number:

1213676

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

grade

puriss.

assay

≥99.0% (T)

mp

199-200 °C (dec.) (lit.), 200-202 °C

SMILES string

Nc1ccc(cc1)C(=O)NCC(O)=O

InChI

1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)

InChI key

HSMNQINEKMPTIC-UHFFFAOYSA-N

说明

Still not finding the right product?

Explore all of our products under 对氨基马尿酸

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Renal hemodynamic response to L-arginine in uncomplicated, type 1 diabetes mellitus: the role of buffering anions and tubuloglomerular feedback.

Alberto Montanari et al.

American journal of physiology. Renal physiology, 303(5), F648-F658 (2012-06-29)

According to the "tubulocentric" hypothesis of the glomerular hyperfiltration of diabetes mellitus (DM), tubuloglomerular feedback (TGF) is the critical determinant of the related renal hemodynamic dysfunction. To examine the role of TGF in human type 1 DM, 12 salt-replete healthy

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.

Maria V Irazabal et al.

Kidney international, 80(3), 295-301 (2011-05-06)

Tolvaptan and related V(2)-specific vasopressin receptor antagonists have been shown to delay disease progression in animal models of polycystic kidney disease. Slight elevations in serum creatinine, rapidly reversible after drug cessation, have been found in clinical trials involving tolvaptan. Here

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.

Justin Koteff et al.

British journal of clinical pharmacology, 75(4), 990-996 (2012-08-22)

Dolutegravir (DTG; S/GSK1349572) is under clinical development as a once daily, unboosted integrase inhibitor for the treatment of HIV infection. The effect of DTG on glomerular filtration rate (GFR), effective renal plasma flow (ERPF), and creatinine clearance (CLcr ) was

查看所有相关文献

全球贸易项目编号

货号	GTIN
126411-5G	04061838724144